Wikidata

(Q82808934)

English

A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)

scientific article published on 13 March 2006

In more languages

Statements

title
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16533873
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533873%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q82808934&oldid=1753257441"